Meta Platforms
META
Coinbase
COIN
Amazon
AMZN
Apple
AAPL
Oracle
ORCL
US Stock MarketDetailed Quotes
SNY Sanofi
- 48.170
- +0.210+0.44%
Close Dec 3 16:00 ET
- 48.600
- +0.430+0.89%
Post 18:22 ET
120.77BMarket Cap25.55P/E (TTM)
48.230High47.985Low2.56MVolume48.210Open47.960Pre Close122.94MTurnover0.12%Turnover Ratio21.34P/E (Static)2.51BShares58.97052wk High1.58P/B106.24BFloat Cap43.38152wk Low2.10Dividend TTM2.21BShs Float58.970Historical High4.35%Div YieldTTM0.51%Amplitude8.844Historical Low48.116Avg Price1Lot Size
About Sanofi Company
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Company Profile
SymbolSNY
Company NameSanofi
Founded1994
CEOMr. Paul Hudson
MarketNASDAQ
Employees87994
Securities TypeDR
ADS Ratio2.0 : 1.0
Fiscal Year Ends12-31
Address46, avenue de la Grande Armée
CityParis
ProvinceIle-de-France
CountryFrance
Zip Code75017
Phone33-1-53-77-40-00
Websitehttp://www.sanofi.com
Company Executives
- Name
- Position
- Salary
- Paul Hudson
- Director and Chief Executive Officer
- --
- Jean-Baptiste Chasseloup De Chatillon
- Executive Vice President and Chief Financial Officer
- --
- Emmanuel Frenehard
- Executive Vice President and Chief Digital Officer
- --
- Natalie Bickford
- Executive Vice President and Chief People Officer
- --
- Madeleine Roach
- Executive Vice President, Business Operations
- --
- Houman Ashrafian
- Executive Vice President and Head of Research and Development
- --
- Julie Van Ongevalle
- Executive Vice President, Consumer Healthcare
- --
- Roy Papatheodorou
- Executive Vice President and General Counsel
- --
- Olivier Charmeil
- Executive Vice President, General Medicines
- --
- Thomas Triomphe
- Executive Vice President, Vaccines
- --
- Brian Foard
- Executive Vice President, Specialty Care
- --
- Brendan O'Callaghan
- Executive Vice President, Global Manufacturing & Supply
- --
- Frederic Oudea
- Chairman of the Board
- --
- Yann Tran
- Director
- --
- Christophe Babule
- Director
- --
- Barbara Lavernos
- Director
- --
- Wolfgang Laux
- Director
- --
- Emile Voest
- Independent Director
- --
- Rachel Duan
- Independent Director
- --
- Thomas Sudhof
- Independent Director
- --
- Diane Souza
- Independent Director
- --
- Fabienne Lecorvaisier
- Independent Director
- --
- Patrick Kron
- Independent Director
- --
- Dr. Antoine Yver, M.D.,M.Sc.
- Independent Director
- --
- Gilles Schnepp
- Independent Director
- --
- Carole Ferrand
- Independent Director
- --
- Lise Kingo
- Independent Director
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
